These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 11339099

  • 1. [Changes in calcium metabolism after kidney transplantation].
    Berczi C, Asztalos L, Kincses Z, Országh I, Löcsey L, Balogh A, Balázs G.
    Magy Seb; 2001 Apr; 54(2):95-100. PubMed ID: 11339099
    [Abstract] [Full Text] [Related]

  • 2. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
    Bro S, Brandi L, Olgaard K.
    Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intravenous alfacalcidol once weekly suppresses parathyroid hormone in hemodialysis patients.
    Al-Hilali N, Al-Humoud H, Al-Helal B, Al-Azmi M, Al-Kandari NH, Johny KV.
    Ther Apher Dial; 2008 Apr; 12(2):137-42. PubMed ID: 18387162
    [Abstract] [Full Text] [Related]

  • 5. Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation.
    Al-Gabri S, Zadrazil J, Krejcí K, Horák P, Bachleda P.
    Transplant Proc; 2005 Mar; 37(2):1014-9. PubMed ID: 15848609
    [Abstract] [Full Text] [Related]

  • 6. Intravenous alfacalcidol once versus twice or thrice weekly in hemodialysis patients.
    Alghareeb A, Sabry A, Bawadekji H, Alsaran K.
    Ther Apher Dial; 2013 Feb; 17(1):30-4. PubMed ID: 23379490
    [Abstract] [Full Text] [Related]

  • 7. Low-dose alfacalcidol controls secondary hyperparathyroidism in predialysis chronic kidney disease.
    Reichel H.
    Nephron Clin Pract; 2010 Feb; 114(4):c268-76. PubMed ID: 20090369
    [Abstract] [Full Text] [Related]

  • 8. Effects of reduced dialysate calcium on calcium-phosphorus product and bone metabolism in hemodialysis patients.
    Fiedler R, Deuber HJ, Langer T, Osten B, Mohan S, Jehle PM.
    Nephron Clin Pract; 2004 Feb; 96(1):c3-9. PubMed ID: 14752247
    [Abstract] [Full Text] [Related]

  • 9. [Hemodialysis with 2.5 mEq/L of calcium in relative hypoparathyroidism: long-term effects on bone mass].
    Sánchez Perales MC, García Cortés MJ, Borrego FJ, Fernández Martínez S, Borrego J, Pérez del Barrio P, Liébana A, Pérez Bañasco V.
    Nefrologia; 2000 Feb; 20(3):254-61. PubMed ID: 10917002
    [Abstract] [Full Text] [Related]

  • 10. Intravenous alfacalcidol once weekly pulse therapy for secondary hyperparathyroidism in hemodialysis patients.
    El-Shafey EM, Alsahow AE, El-Nagar GF, Ezzat A.
    Ren Fail; 2011 Feb; 33(3):329-33. PubMed ID: 21401359
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C.
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [Abstract] [Full Text] [Related]

  • 13. Effects of lowering dialysate calcium concentration on mineral metabolism and hemodynamic parameters in hemodialysis patients.
    Alayoud A, El Kabbaj D, Benyahia M, Asseraji M, Zemraoui N.
    Iran J Kidney Dis; 2015 Mar; 9(2):132-7. PubMed ID: 25851292
    [Abstract] [Full Text] [Related]

  • 14. Long-term evolution of the mineral metabolism after renal transplantation: a prospective, single-center cohort study.
    Van de Cauter J, Sennesael J, Haentjens P.
    Transplant Proc; 2011 Nov; 43(9):3470-5. PubMed ID: 22099822
    [Abstract] [Full Text] [Related]

  • 15. Magnesium deficiency and bone loss after cardiac transplantation.
    Boncimino K, McMahon DJ, Addesso V, Bilezikian JP, Shane E.
    J Bone Miner Res; 1999 Feb; 14(2):295-303. PubMed ID: 9933485
    [Abstract] [Full Text] [Related]

  • 16. Disorders of calcium metabolism at various times after renal transplantation.
    Babarykin D, Adamsone I, Amerika D, Folkmane I, Rozental R.
    Ann Transplant; 1999 Feb; 4(1):46-53. PubMed ID: 10850601
    [Abstract] [Full Text] [Related]

  • 17. [Changes in calcium metabolism after parathyroidectomy in primary hyperparathyroidism].
    Berczi C, Balogh A, Balázs G, Lukács G.
    Orv Hetil; 2002 Mar 24; 143(12):597-600. PubMed ID: 11963396
    [Abstract] [Full Text] [Related]

  • 18. Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism.
    Laway BA, Goswami R, Singh N, Gupta N, Seith A.
    Clin Endocrinol (Oxf); 2006 Apr 24; 64(4):405-9. PubMed ID: 16584512
    [Abstract] [Full Text] [Related]

  • 19. Rapid loss of vertebral mineral density after renal transplantation.
    Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD.
    N Engl J Med; 1991 Aug 22; 325(8):544-50. PubMed ID: 1857390
    [Abstract] [Full Text] [Related]

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 22; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.